How to buy Applied DNA Sciences stock | $5.79

Applied DNA Sciences, Inc is a security & protection services business based in the US. Applied DNA Sciences shares (APDN) are listed on the NASDAQ and all prices are listed in US Dollars. Applied DNA Sciences employs 59 staff and has a trailing 12-month revenue of around 0.00.

Applied DNA Sciences stock price (NASDAQ: APDN)

Use our graph to track the performance of APDN stocks over time.

Applied DNA Sciences shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$5.79
52-week range	$4.95 - $13.64
50-day moving average	$6.17
200-day moving average	$7.64
Wall St. target price	$18.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.32

Buy Applied DNA Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Applied DNA Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Applied DNA Sciences, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied DNA Sciences price performance over time

Historical closes compared with the close of $5.79 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	-8.96%
3 months (2021-04-30)	-15.72%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

Applied DNA Sciences financials

Revenue TTM	$5 million
Gross profit TTM	$1.2 million
Return on assets TTM	-48.78%
Return on equity TTM	-106.14%
Profit margin	-272.96%
Book value	$2.49
Market capitalisation	$38.7 million

TTM: trailing 12 months

Shorting Applied DNA Sciences shares

There are currently 280,386 Applied DNA Sciences shares held short by investors – that's known as Applied DNA Sciences's "short interest". This figure is 17% down from 337,823 last month.

There are a few different ways that this level of interest in shorting Applied DNA Sciences shares can be evaluated.

Applied DNA Sciences's "short interest ratio" (SIR)

Applied DNA Sciences's "short interest ratio" (SIR) is the quantity of Applied DNA Sciences shares currently shorted divided by the average quantity of Applied DNA Sciences shares traded daily (recently around 91629.411764706). Applied DNA Sciences's SIR currently stands at 3.06. In other words for every 100,000 Applied DNA Sciences shares traded daily on the market, roughly 3060 shares are currently held short.

However Applied DNA Sciences's short interest can also be evaluated against the total number of Applied DNA Sciences shares, or, against the total number of tradable Applied DNA Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Applied DNA Sciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Applied DNA Sciences shares in existence, roughly 30 shares are currently held short) or 0.0419% of the tradable shares (for every 100,000 tradable Applied DNA Sciences shares, roughly 42 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Applied DNA Sciences.

Find out more about how you can short Applied DNA Sciences stock.

Applied DNA Sciences share dividends

We're not expecting Applied DNA Sciences to pay a dividend over the next 12 months.

Have Applied DNA Sciences's shares ever split?

Applied DNA Sciences's shares were split on a 1:40 basis on 31 October 2019. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Applied DNA Sciences shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Applied DNA Sciences shares which in turn could have impacted Applied DNA Sciences's share price.

Applied DNA Sciences share price volatility

Over the last 12 months, Applied DNA Sciences's shares have ranged in value from as little as $4.95 up to $13.64. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied DNA Sciences's is 1.0332. This would suggest that Applied DNA Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Applied DNA Sciences overview

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc.

Frequently asked questions

What percentage of Applied DNA Sciences is owned by insiders or institutions?
Currently 10.456% of Applied DNA Sciences shares are held by insiders and 26.969% by institutions. How many people work for Applied DNA Sciences?
Latest data suggests 59 work at Applied DNA Sciences. When does the fiscal year end for Applied DNA Sciences?
Applied DNA Sciences's fiscal year ends in September. Where is Applied DNA Sciences based?
Applied DNA Sciences's address is: 50 Health Sciences Drive, Stony Brook, NY, United States, 11790 What is Applied DNA Sciences's ISIN number?
Applied DNA Sciences's international securities identification number is: US03815U3005 What is Applied DNA Sciences's CUSIP number?
Applied DNA Sciences's Committee on Uniform Securities Identification Procedures number is: 03815U102